Total planned funding: $195,130,626
Allocations
Countries/Regions
| Eswatini | $195,130,626 |
Organizational Types
| Private Contractor | $51,268,083 |
| NGO | $40,818,371 |
| University | $33,382,456 |
| Own Agency | $27,708,854 |
| Unknown | $24,255,654 |
| Multi-lateral Agency | $7,309,130 |
| Host Country Government Agency | $5,186,291 |
| FBO | $3,166,021 |
| Other USG Agency | $1,866,166 |
| Implementing Agency | $169,600 |
Program Areas
| Care | $66,234,210 |
| Treatment | $38,783,008 |
| Prevention | $37,969,327 |
| Governance and Systems | $22,514,659 |
| Management and Operations | $16,182,073 |
| Testing | $13,447,349 |
Budget Codes
| HBHC: Care: Adult Care and Support | $30,407,738 |
| HTXS: Treatment: Adult Treatment | $27,507,059 |
| HKID: Care: Orphans and Vulnerable Children | $19,543,684 |
| HVMS: Management and Operations | $16,182,073 |
| HVCT: Testing: HIV Testing and Counseling | $13,447,349 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,064,608 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $12,216,172 |
| OHSS: Health Systems Strengthening | $10,207,998 |
| HVTB: Care: TB/HIV | $9,219,104 |
| HVSI: Strategic Information | $8,264,431 |
| HTXD: Treatment: ARV Drugs | $7,892,626 |
| PDCS: Care: Pediatric Care and Support | $7,063,684 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,819,524 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,939,052 |
| HLAB: Laboratory Infrastructure | $4,042,230 |
| PDTX: Treatment: Pediatric Treatment | $3,383,323 |
| HMBL: Biomedical Prevention: Blood Safety | $1,929,971 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$30,112,065
Countries/Regions
Pact, Inc.:
$24,421,760
Countries/Regions
Not Available:
$24,105,654
Countries/Regions
USG Aggregated Agencies:
$18,353,927
Countries/Regions